3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 49.85
-0.05 (-0.10%)
Sep 17, 2025, 1:59 PM CST
3D Global Biotech Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| 324.87 | 265.69 | 20.63 | 13.64 | 11.08 | 13.26 | Upgrade | |
Revenue Growth (YoY) | 489.06% | 1187.67% | 51.23% | 23.19% | -16.48% | -27.05% | Upgrade |
Cost of Revenue | 99.28 | 91.18 | 15.36 | 10.93 | 9.27 | 8.29 | Upgrade |
Gross Profit | 225.59 | 174.51 | 5.27 | 2.72 | 1.8 | 4.97 | Upgrade |
Selling, General & Admin | 55.19 | 42.54 | 29.53 | 29.53 | 26.41 | 19.68 | Upgrade |
Research & Development | 43.13 | 43.27 | 38.6 | 39.48 | 37.6 | 35.62 | Upgrade |
Operating Expenses | 98.65 | 86.02 | 68.13 | 69 | 64.01 | 55.3 | Upgrade |
Operating Income | 126.94 | 88.49 | -62.85 | -66.29 | -62.21 | -50.33 | Upgrade |
Interest Expense | -0.91 | -0.12 | -0.18 | -0.26 | -0.26 | -0.1 | Upgrade |
Interest & Investment Income | 11.09 | 6.19 | 2.24 | 1.68 | 1.35 | 1.71 | Upgrade |
Currency Exchange Gain (Loss) | 1.3 | 1.3 | 0.02 | -0.01 | 0 | - | Upgrade |
Other Non Operating Income (Expenses) | -13.98 | 0.14 | 1.85 | 0.62 | 0.15 | 0.24 | Upgrade |
EBT Excluding Unusual Items | 124.44 | 96 | -58.92 | -64.25 | -60.97 | -48.48 | Upgrade |
Gain (Loss) on Sale of Assets | 0 | 0 | - | - | - | - | Upgrade |
Asset Writedown | - | - | - | -18.89 | - | - | Upgrade |
Other Unusual Items | 0.07 | 0.07 | - | 0.01 | - | - | Upgrade |
Pretax Income | 124.51 | 96.07 | -58.92 | -83.13 | -60.97 | -48.48 | Upgrade |
Income Tax Expense | -9.37 | 4.37 | -0.96 | -16.05 | -1.26 | -0.56 | Upgrade |
Net Income | 133.88 | 91.7 | -57.95 | -67.09 | -59.71 | -47.92 | Upgrade |
Net Income to Common | 133.88 | 91.7 | -57.95 | -67.09 | -59.71 | -47.92 | Upgrade |
Shares Outstanding (Basic) | 79 | 69 | 56 | 55 | 54 | 54 | Upgrade |
Shares Outstanding (Diluted) | 82 | 71 | 56 | 55 | 54 | 54 | Upgrade |
Shares Change (YoY) | 44.33% | 26.08% | 2.32% | 1.69% | 0.77% | 6.02% | Upgrade |
EPS (Basic) | 1.69 | 1.33 | -1.03 | -1.22 | -1.11 | -0.89 | Upgrade |
EPS (Diluted) | 1.64 | 1.30 | -1.03 | -1.22 | -1.11 | -0.89 | Upgrade |
Free Cash Flow | 89.09 | 14.91 | -32.39 | -35.33 | -38.85 | -23.26 | Upgrade |
Free Cash Flow Per Share | 1.09 | 0.21 | -0.58 | -0.64 | -0.72 | -0.43 | Upgrade |
Dividend Per Share | 0.530 | 0.530 | - | - | - | - | Upgrade |
Gross Margin | 69.44% | 65.68% | 25.56% | 19.91% | 16.28% | 37.49% | Upgrade |
Operating Margin | 39.07% | 33.31% | -304.62% | -485.87% | -561.71% | -379.52% | Upgrade |
Profit Margin | 41.21% | 34.52% | -280.87% | -491.73% | -539.10% | -361.34% | Upgrade |
Free Cash Flow Margin | 27.42% | 5.61% | -156.99% | -258.98% | -350.81% | -175.38% | Upgrade |
EBITDA | 146.67 | 104.62 | -46.49 | -47.15 | -42.46 | -30.41 | Upgrade |
EBITDA Margin | 45.15% | 39.38% | -225.30% | - | - | -229.35% | Upgrade |
D&A For EBITDA | 19.73 | 16.13 | 16.37 | 19.14 | 19.75 | 19.91 | Upgrade |
EBIT | 126.94 | 88.49 | -62.85 | -66.29 | -62.21 | -50.33 | Upgrade |
EBIT Margin | 39.07% | 33.31% | - | - | - | - | Upgrade |
Effective Tax Rate | - | 4.55% | - | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.